Close Menu
    2digital.news2digital.news
    • News
    • Analytics
    • Interviews
    • About us
    • Editorial board
    • Events
    2digital.news2digital.news
    Home»About us

    About us

    We are a media outlet focused on technology and digital health. In a world where data, opinion, and synthetic signals blur, we treat “facts” as claims that earn their status through method, not repetition. Some truths are hard, like Newton’s physics. Others are conditional — true within assumptions, models, or time windows. We make that spectrum explicit.

    As information volume explodes, reality gets slippery. Misinformation offers grip, then drags the world out of focus. We respect uncertainty and fight misinformation by tracing claims back to primary evidence, looking for independent confirmation, and publishing updates when better data arrives. Expert views help us interpret complicated topics. Where experts disagree, we map the disagreement and the tests that could resolve it. Leaders deserve clarity that is honest about what we know, what we don’t, and what would change our minds.

    Our mission is to help health and tech leaders make evidence‑based, regulation‑ready decisions by reducing noise and translating what matters into practical steps for care and operations.

    Our values: Transparency, Evidence, Independence, Accessibility.

    What we publish

    We cover digital health, medical software, AI, data governance, devices and diagnostics, health‑policy and market shifts, and the business of health tech. Our formats include news, analysis, explainers, interviews, data‑driven features, investigations, newsletters, webinars and, when clearly labeled, sponsored or partner pieces.

    How we work

    Every article goes through editorial review for accuracy, clarity, and fairness. We analyze scientific publications and regulatory filings, interview experts, examine real‑world deployments, and inspect the provenance of datasets and graphics. We prefer primary sources. Press releases and marketing materials are used only to locate original documents.

    Our evidence ladder

    We analyze scientific publications, interview experts, and examine real-world cases of technology adoption in healthcare. Every article undergoes editorial review to ensure it meets our standards of accuracy and clarity. If we make a mistake, we correct it openly.

    Sources and verification

    We attribute facts to their sources in the text or footnotes. Numbers, dates, job titles, and quotes are checked before publication.
    Preprints are labeled as such. Conference abstracts are treated cautiously until a full paper or data are available.
    Anonymous sources are rare and require a clear public‑interest rationale. Editors must know the source’s identity and assess credibility. When we rely on anonymity, we explain why.
    For critical allegations we offer a right of reply and include responses where material.

    Independence and conflicts

    Editorial decisions are independent of sponsors, investors, and advertisers. Reporters and editors disclose personal or financial conflicts annually and per article.
    Advertising, sponsorship, and commercial content
    Advertising has no control over our journalism. Sponsored and partner content follows a separate workflow and is labeled at the top of the page as “Sponsored,” “Partner Content,” or “Advertorial.” Such pieces may not make clinical or regulatory claims without primary evidence. Native ads never mimic our news format.
    Corrections and updates
    We correct errors openly. Typos and formatting fixes may be updated silently with a timestamp; substantive corrections — numbers, names, or claims — receive a correction box at the top. If a piece is fundamentally flawed, we retract it and leave a notice at the original URL. Targets: breaking items within 24 hours of learning of the error; longer features within 72 hours.
    Embargoes and pre‑publication materials
    We honor legitimate embargoes and verify embargoed claims against source documents when they lift. We do not accept conditions that limit our independent analysis.
    Expert viewpoints
    We welcome expert commentary, but experts are not neutral by default. We disclose relevant affiliations and funding when they are material. Where experts disagree, we show the disagreement and the tests or data that could resolve it.

    AI assistance

    We may use ai tools for research assistance, transcript clean-up, or drafting outlines. ai is never used to invent sources or quotes. Editors review all ai‑assisted work before publication. If ai materially shapes a data analysis or graphic, we say so in an accompanying note and provide the underlying method.

    Data and graphics

    Charts must be reproducible from the stated sources. We publish methods notes for complex figures and avoid deceptive scales. When uncertainty matters, we show it.
    Accessibility and translations
    We write in clear language and explain specialized terms. Alt‑text accompanies important images and charts. For translations, an editor fluent in the target language reviews the final text to ensure accuracy and tone.
    Privacy and security
    We follow GDPR for personal data and handle sensitive material with care. We do not upload confidential or embargoed documents to external tools without approval.
    Who we write for

    IT strategists and informatics professionals interested in standards, interoperability, and implementation.

    Tech and medtech innovators working to generate credible evidence for digital solutions.

    Investors who need to understand product efficacy and evidence strength.

    Healthcare professionals and clinical leaders who want practical ways to fit digital tools into workflow and reduce burden.

    Read more

    Will We All Become Cyborgs?

    February 20, 2026

    AI-predicted insulin resistance as a potential cancer risk factor. Data from 370 thousand people

    February 19, 2026

    Ozempic Alternatives in 2026: What Can Replace the Most Famous Weight-Loss Drug?

    February 17, 2026
    Stay in touch
    • Twitter
    • Instagram
    • LinkedIn
    • Threads
    Demo
    X (Twitter) Instagram Threads LinkedIn
    • NEWS
    • ANALYTICS
    • INTERVIEWS
    • ABOUT US
    • EDITORIAL BOARD
    • EVENTS
    • CONTACT US
    • ©2026 2Digital. All rights reserved.
    • Privacy policy.

    Type above and press Enter to search. Press Esc to cancel.